Literature DB >> 31942576

Oral lichen planus and lichenoid lesions: what's new?

Andrea Maria Schmidt-Westhausen.   

Abstract

In recent years, a large number of studies have been published evaluating the therapy of oral lichen planus. In addition to standard medication such as topical glucocorticoid therapy, substances such as Aloe vera, hyaluronic acid, and treatments from traditional Chinese medicine have also been investigated. It is not always easy for dental practitioners to find an adequate therapy according to the clinical picture. This article presents therapies for dental practitioners who do not focus on treating patients with oral mucosa diseases. Oral lichenoid lesions, which are clinically and histologically similar, must be distinguished from oral lichen planus. Before starting therapy, it is necessary to differentiate between drug- and contact-related variants. Both clinical features have in common that according to the World Health Organization (2017) they belong to the class of potentially malignant disorders. Accordingly, these patients must be referred to a regular, and in oral lichen planus patients, lifelong, recall.

Entities:  

Keywords:  oral lichen planus; oral lichenoid lesion; topical glucocorticoids

Mesh:

Substances:

Year:  2020        PMID: 31942576     DOI: 10.3290/j.qi.a43868

Source DB:  PubMed          Journal:  Quintessence Int        ISSN: 0033-6572            Impact factor:   1.677


  2 in total

1.  Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.

Authors:  Qing-Mei Wang; Xue-Ying Huang; Wei-Qun Guan
Journal:  Inflammation       Date:  2022-01-22       Impact factor: 4.092

Review 2.  Oral lichenoid lesion in association with chemotherapy treatment for non-Hodgkin lymphoma or lichen planus? Review of the literature and report of two challenging cases.

Authors:  Letícia Côgo Marques; Laiza Angela de Medeiros Nunes da Silva; Pâmella de Pinho Montovani Santos; Amanda de Almeida Lima Borba Lopes; Karin Soares Cunha; Adrianna Milagres; Rafaela Elvira Rozza-de-Menezes; Arley Silva Junior; Danielle Castex Conde
Journal:  Head Face Med       Date:  2022-09-06       Impact factor: 2.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.